brryh, I think that what you hope will happen quite soon with PBT2. I believe that the commercialization deal will be finalized this year or now any day before Christmas. With ATH434 we need to get phase 2 results but then a safe iron chelator will have many potential usages.
Mitochondrion dysfunctions in early PD, page-3
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $5.1K | 1.02M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 48 | 69461182 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 21658481 | 10 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 10.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 1258823 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| ATH (ASX) Chart |